Back to Search
Start Over
99m Tc-MIBI SPECT/CT Evaluation of a Renal Collision Tumor.
- Source :
-
Clinical nuclear medicine [Clin Nucl Med] 2023 Aug 01; Vol. 48 (8), pp. e390-e392. Date of Electronic Publication: 2023 Jun 17. - Publication Year :
- 2023
-
Abstract
- Abstract: Preoperative differentiation of oncocytomas from renal cell carcinoma (RCC) is often challenging. 99m Tc-MIBI imaging could play a potential role in differentiating oncocytoma from RCC, which in turn could guide surgical decision-making. We present the use of 99m Tc-MIBI SPECT/CT to characterize a renal mass in a 66-year-old man with a complex medical history, including history of bilateral oncocytomas. 99m Tc-MIBI SPECT/CT showed features suspicious of a malignant tumor, which was confirmed postnephrectomy as a chromophobe and papillary RCC collision tumor. This case supports 99m Tc-MIBI imaging for preoperative differentiation of benign versus malignant renal tumors.<br />Competing Interests: Conflicts of interest and sources of funding: none declared.<br /> (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Subjects :
- Male
Humans
Aged
Diagnosis, Differential
Single Photon Emission Computed Tomography Computed Tomography
Technetium Tc 99m Sestamibi
Carcinoma, Renal Cell diagnostic imaging
Carcinoma, Renal Cell pathology
Kidney Neoplasms diagnostic imaging
Kidney Neoplasms pathology
Adenoma, Oxyphilic diagnostic imaging
Adenoma, Oxyphilic pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1536-0229
- Volume :
- 48
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Clinical nuclear medicine
- Publication Type :
- Academic Journal
- Accession number :
- 37335313
- Full Text :
- https://doi.org/10.1097/RLU.0000000000004729